Chiome’s monoclonal antibody discovery engine also includes technologies to prepare soluble proteins and membrane proteins for research, and create antibody-based multi-specific modalities.

To enable antibody discovery, membrane protein scientists at TetraGenetics encapsulate and stabilize purified protein in an artificial bilayer with immune-stimulating molecules to generate ...

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

Membrane proteins are key targets for therapeutic intervention using antibody biologics. Over 60% of FDA-approved drugs act on these proteins. Studying them is challenging because the proteins ...

Integral Molecular, a leading biotechnology company in Philadelphia, is honored to announce its recognition as an Employer of ...

i-Ome™ Discovery is Sengenics’ most advanced protein microarray, meticulously designed for antibody and autoantibody profiling in biomarker discovery. This powerful platform delivers key insights into ...

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...

Research led by Brock University has found a possible cure for lung diseases typically found in older adults, such as pulmonary fibrosis. The findings are published in the journal Aging Cell.